Biotech

Latest Articles

Former Seagen CEO reveals brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer last year f...

Ironwood makes further purpose $1B GI drug along with brand new subgroup records

.On the heels of a period 3 gain that failed to impress investors, Ironwood Pharmaceuticals is back ...

Novartis inks $150M bargain for autoimmune molecular adhesive

.Do not quit Monte Rosa Therapies currently. The Boston-based biotech is actually having a ball afte...

Jade takes director crew along with Chinook veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, firings and ...

Septerna goes public with upsized offering of $288M

.Celebrating his provider's upsized going public (IPO), Septerna chief executive officer Jeffrey Fin...

AbbVie creates Richter wealthier, paying for $25M to form breakthrough deal

.AbbVie has come back to the source of its antipsychotic goliath Vraylar trying to find an additiona...

GenSight goes into ultimate weeks of cash money path as earnings stream squeezes by of grasp

.GenSight Biologics is weeks far from running out of loan. Again. The biotech simply has enough cash...

AZ licenses discarded unusual condition drug to Monopar Therapies

.Monopar Therapies is recuperating a medication coming from the dump of AstraZeneca's unusual ailmen...

Arcus' new HIF-2a records in kidney cancer mention possible advantage over Merck's Welireg, analysts claim

.Along with new records out on Arcus Biosciences' experimental HIF-2a prevention, one team of expert...

Roche bets as much as $1B to grow Dyno genetics therapy distribution treaty

.After forming a gene treatment collaboration with Dyno Rehabs in 2020, Roche is back for additional...

Lundbeck slashes worth of $250M Abide buyout after pain setback

.Lundbeck is actually reducing guide market value of its own $250 million Abide Therapeutics acquist...

Real- Globe Data Fulfills Professional Trial Concept: Improving Process and also Web Site Variety

.The combination of real-world information (RWD) right into procedure workability and also website s...

Where are they today? Catching up with past Fierce 15 honorees

.At this year's Fierce Biotech Peak in Boston, our team overtook innovators in the biotech business ...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually taking down $30 million beforehand to acquire Yale spinout Modifi Biosci...

Radiopharma Alpha-9 elevates $175M series C to fund scientific press

.Alpha-9 Oncology has increased a $175 million series C round to stake its clinical-stage radiopharm...

Ocuphire to enhance in to genetics therapy biotech using Piece acquistion

.Eye medication producer Ocuphire Pharma is actually getting genetics therapy developer Piece Genes ...

Roche culls hack applicant, rotates KRAS program in Q3 improve

.Roche's chronic cough course has faltered to a standstill. The drugmaker, which axed the program af...

Merck- Gilead long-acting dental combo subdues HIV for 48 weeks

.Gilead Sciences and Merck &amp Co. have actually assisted their once-weekly HIV mixture treatment p...

Lykos takes FDA look at that MDMA authorization counts on new test

.Lykos Therapies might possess shed three-quarters of its own staff in the wake of the FDA's rejecti...

Septerna intends $158M IPO to finance readouts for GPCR pipe

.Septerna may be yet to divulge "any significant scientific data," but the biotech plainly thinks th...